Key result
Genetically predicted β-hydroxybutyrate is linked to ~59% higher coronary atherosclerosis risk.
Why the study?
Ketone bodies are implicated in cardiovascular metabolism, yet the specific contributions of β-hydroxybutyrate, acetoacetate, and acetone to coronary atherosclerosis remain unclear.
Does genetically predicted β-hydroxybutyrate or other ketone bodies increase the risk of coronary atherosclerosis?
Does genetically predicted β-hydroxybutyrate or other ketone bodies increase the risk of coronary atherosclerosis?
Identifies β-hydroxybutyrate as the primary ketone body genetically associated with increased coronary atherosclerosis susceptibility and defines an APOE-linked five-gene plaque signature for molecular stratification.
Answers are grounded in this paper and cite their sources.
Ketone body associations with atherosclerosis remain inconclusive; leaves open causal roles and precludes clinical adoption.
Aims Ketone bodies are implicated in cardiovascular metabolism, yet the contributions of β‐hydroxybutyrate (BHB), acetoacetate and acetone to coronary atherosclerosis remain unclear. Methods We integrated Mendelian randomization (MR), cross‐trait GWAS analysis, ApoE pQTL‐MR and colocalization to investigate genetic associations with coronary atherosclerosis, complemented by bulk transcriptomic analysis, machine learning‐based signature construction, immune infiltration analysis and single‐cell analysis to characterize APOE ‐associated molecular features in human atherosclerotic plaques. Results Genetically predicted BHB was associated with coronary atherosclerosis risk in univariable MR (OR = 1.59, 95% CI: 1.29–1.95, p = 8.8 × 10 −6 ) and remained significant after mutual adjustment for acetoacetate and acetone (OR = 1.58, 95% CI: 1.14–2.18, p = 0.005), whereas neither acetoacetate nor acetone showed a significant association. Cross‐trait gene prioritization highlighted APOE for further investigation. ApoE pQTL‐MR supported an association between genetically predicted ApoE and coronary atherosclerosis (OR = 1.23, p = 0.003). Weighted gene co‐expression network analysis (WGCNA) and machine‐learning algorithms, including LASSO, random forest, SVM‐RFE and XGBoost, identified an APOE ‐associated five‐gene signature comprising XAF1 , CEP128 , TMEM106A , VEPH1 and ABCB1 . The signature achieved an apparent AUC of 0.956 in GSE43292 and AUCs of 0.974 in GSE100927 and 0.736 in GSE28829. High signature scores were associated with immune‐inflammatory changes. Single‐cell analysis showed enrichment of the signature in macrophages, endothelial cells and fibroblasts, while CellChat analysis identified a macrophage‐centred pattern of inferred cell–cell communication. Conclusions These findings identify BHB as the ketone body most strongly associated with coronary atherosclerosis susceptibility and define an APOE ‐associated multicellular signature in human atherosclerotic plaques with potential value for molecular stratification.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied Coronary atherosclerosis. Genetically predicted β-hydroxybutyrate (BHB), acetoacetate, acetone, and ApoE was evaluated on Coronary atherosclerosis risk (OR 1.59, 95% CI 1.29-1.95, p=8.8 × 10^-6). Genetically predicted β-hydroxybutyrate was associated with increased coronary atherosclerosis risk (OR 1.59, 95% CI 1.29-1.95, p=8.8×10^-6).
Synapse has enriched 10 related papers. Consider them for comparative context: